|Day Low/High||42.77 / 43.21|
|52 Wk Low/High||37.12 / 46.47|
Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.
The cancer drug market is expected to grow from a surveyed total value of $78 billion in 2015 to over $110 billion by 2020.
Jim Cramer responds to the news that the drug company, Pfizer, has hiked rates.
Let's check our indicators.
U.S. stocks futures indicated a firmer open Monday, even as reports suggest Renault CEO Carlos Ghosn faces arrest in Japan after Nissan said he had misused company funds and will be ousted as chairman; Apple is sliding again on fresh iPhone demand reports; U.S.-China trade tensions simmer; Bitcoin falls to a 13-month low and Pfizer plans 2019 durg price hikes.
Jim Cramer says perception is determining how stocks trade right now -- and there's a lot of negativity.
The most recent short interest data has been released for the 10/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
A split Congress is the best-case scenario for the drug industry, several analysts said.
Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.
The Dow Jones Industrial Average is a price-weighted average of 30 large American publicly traded companies on the stock market.
And keep in mind that earnings season is not over, and there's enough juice left to impact the marketplace.
Pfizer Inc. (NYSE:PFE) today announced that the U.
Stephen 'Sarge' Guilfoyle gives you a rundown of what's in his portfolio as the new month gets rolling.
Once the safest stocks in the book, the big-cap drug companies are now toxic.
Some groups that have been in horrendous bear market mode finally caught a bid.
The Dow Jones Industrial Average led major market indexes higher with a late surge Tuesday after closing lower during the previous session for the eighth time in 11 trading days.
Pfizer posts stronger-than-expected third-quarter earnings but narrows its guidance range for full-year sales.
Global stocks attempted yet another rebound Tuesday, with reports of direction market intervention in China supporting prices in Asia and stronger-than-expected blue chip earnings putting European bourses on solid footing following a volatile session on Wall Street that saw a 900-point swing for the Dow Jones Industrial Average and a further worrying plunge in big-name tech companies.
U.S. stock futures rise modestly on Tuesday following a volatile session on Wall Street that saw a 900-point swing for the Dow Jones Industrial Average; Facebook, GE, Coca-Cola and Pfizer report earnings; Apple is expected to unveil a new iPad and perhaps a new MacBook Air at an event Tuesday.
TheStreet takes a look at the final week of Q3 earnings.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
Pfizer Inc. (NYSE:PFE) reported financial results for third-quarter 2018 and narrowed certain 2018 financial guidance ranges.
Pfizer Inc. (NYSE:PFE) announced today that it has entered into a non-exclusive clinical development agreement with Novartis (NYSE: NVS) to investigate one or more combination therapies for the treatment of non-alcoholic steatohepatitis (NASH).
A lot of names now suddenly present as dividend plays that maybe we do not think of in that way.
It becomes difficult for me to tell you where to run in these markets...
Walmart -- with great growth -- sparks optimism, but Jim Cramer says it's not the only stock to fuel the day's rally.
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.